CADL
Price
$5.22
Change
+$0.25 (+5.03%)
Updated
Apr 14, 04:16 PM (EDT)
Capitalization
234.76M
24 days until earnings call
PRTA
Price
$9.95
Change
-$0.28 (-2.74%)
Updated
Apr 14, 04:55 PM (EDT)
Capitalization
550.11M
23 days until earnings call
Ad is loading...

CADL vs PRTA

Header iconCADL vs PRTA Comparison
Open Charts CADL vs PRTABanner chart's image
Candel Therapeutics
Price$5.22
Change+$0.25 (+5.03%)
Volume$2.2K
Capitalization234.76M
Prothena
Price$9.95
Change-$0.28 (-2.74%)
Volume$4.02K
Capitalization550.11M
CADL vs PRTA Comparison Chart
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CADL vs. PRTA commentary
Apr 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and PRTA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 14, 2025
Stock price -- (CADL: $4.97 vs. PRTA: $10.22)
Brand notoriety: CADL and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 46% vs. PRTA: 95%
Market capitalization -- CADL: $234.76M vs. PRTA: $550.11M
CADL [@Biotechnology] is valued at $234.76M. PRTA’s [@Biotechnology] market capitalization is $550.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, PRTA is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while PRTA’s TA Score has 4 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 6 bearish.
  • PRTA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PRTA is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а -5.33% price change this week, while PRTA (@Biotechnology) price change was -5.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.64%. For the same industry, the average monthly price growth was -15.25%, and the average quarterly price growth was -23.60%.

Reported Earning Dates

CADL is expected to report earnings on Sep 03, 2025.

PRTA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTA($550M) has a higher market cap than CADL($235M). PRTA YTD gains are higher at: -26.209 vs. CADL (-42.742). CADL has higher annual earnings (EBITDA): -48.83M vs. PRTA (-153.67M). PRTA has more cash in the bank: 471M vs. CADL (16.6M). PRTA has less debt than CADL: PRTA (10.8M) vs CADL (16M). PRTA has higher revenues than CADL: PRTA (135M) vs CADL (0).
CADLPRTACADL / PRTA
Capitalization235M550M43%
EBITDA-48.83M-153.67M32%
Gain YTD-42.742-26.209163%
P/E RatioN/AN/A-
Revenue0135M-
Total Cash16.6M471M4%
Total Debt16M10.8M148%
FUNDAMENTALS RATINGS
PRTA: Fundamental Ratings
PRTA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLPRTA
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 6 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 29 days ago
86%
Bullish Trend 22 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
74%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Ad is loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBAX63.062.16
+3.55%
Rydex Basic Materials H
VEUAX32.800.86
+2.69%
JPMorgan Europe Dynamic A
SCAUX10.390.17
+1.66%
Invesco Income Advantage U.S. Fund A
GLPSX36.980.60
+1.65%
Goldman Sachs MLP Energy Infras R6
ACIPX14.820.22
+1.51%
American Century Mid Cap Value G

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+4.19%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
39%
Loosely correlated
N/A
MDGL - CADL
33%
Poorly correlated
+3.19%
PRTA - CADL
31%
Poorly correlated
+5.47%
KRRO - CADL
31%
Poorly correlated
-0.54%
More